US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist
  • 32.360
  • -0.100-0.31%
Close Feb 14 16:00 ET
  • 32.008
  • -0.352-1.09%
Post 17:16 ET
14.02BMarket Cap16.94P/E (TTM)

Royalty Pharma Key Stats

Royalty Pharma Q4 2024 Earnings Date

Currency:USDFeb 11, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
743.60M
593.64M
-149.96M
Miss Est.
+24.77%
-0.41%
-20.17%
EPS
0.25
0.35
+0.10
Beat Est.
-77.27%
-67.90%
+41.24%
Strong Buy

Feb 12, 2025

Royalty Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 654.000M--
--2025/Q1-- / 806.000M--
Feb 11, 20252024/Q4594.000M / 743.604M--
Nov 6, 20242024/Q3565.000M / 731.832M--
Aug 8, 20242024/Q2537.000M / 645.290M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 654.000M--
--2025/Q1-- / 806.000M--
Feb 11, 20252024/Q4594.000M / 743.604M--
Nov 6, 20242024/Q3565.000M / 731.832M--
Aug 8, 20242024/Q2537.000M / 645.290M--

Unlock Free Earnings Estimates

Royalty Pharma Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 12, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data